Blog& Insights_Hangzhou Healsun Biopharm Co.,Ltd.

新闻

最新资讯

传递热点，提升价值

Comparative Analysis of N-1 Perfusion Strategies for Enhanced Protein Expression and Cost Efficiency in Biopharmaceutical Manufacturing

2024 / 06 / 21 了解详情 >>
Method Validation: Elevate your shooting precision in the course of Process Development

2023 / 08 / 31 了解详情 >>
Construction of CHO Cell Lines Expressing Antibodies with Low Fucose Level by Gene Editing Technolog

2023 / 08 / 17 了解详情 >>
Antibody Disulfide Bonds and ADCs

2023 / 08 / 09 了解详情 >>
Read the Coffee Grounds -- Stability Study During Cell Line Construction

2023 / 07 / 26 了解详情 >>
Get ahead in the race for CMC development success - Accelerating CMC development for bispecific anti

2023 / 07 / 06 了解详情 >>
Feeding Development-Sphinx Riddle

2023 / 08 / 24 了解详情 >>
资讯 | 扬帆浩瀚，陟遐自迩——开启新篇章

2023 / 05 / 04 了解详情 >>
资讯 I 皓阳生物获评“2022年度浙江省第二批专精特新中小企业名单”

2023 / 02 / 01 了解详情 >>

<
1
2
>

Email：healsunbd@hs-biopharm.com

Early-Stage
Biologics ADC Protein Store
CMC Process
Cell Line Development Biologics Process Development ADC Process Development Analytical Support
GMP Pilot Production
Biologics ADC
Commercial Production
PC/PV Commercial Production
CGT
Exosome mRNA AAV
Biosimilars
Biosimilars
About Us
Company Profile VR Tour Contact Us

Copyright © 2023 杭州皓阳生物技术有限公司All Rights Reserved 浙ICP备16013229号-1 浙公网安备 33011002011493号技术支持：杭州网站制作